Dominari的COO在12月5日出售了140,000股股票, Dominari’s COO sold 140,000 shares Dec. 5, reducing his stake to ~370K shares, per SEC filing.

Dominari首席操作官Christopher Franklin Devall于2025年12月5日出售140 000股股票,每股3.82美元,共计534 800美元,此前12月3日出售了40 000股。 Christopher Franklin Devall, Dominari’s Chief Operating Officer, sold 140,000 shares on December 5, 2025, at $3.82 each, totaling $534,800, following a prior sale of 40,000 shares on December 3. 在交易后,他的所有权大幅下降,使他拥有价值156万美元的约370 702份股票。 After the transactions, his ownership dropped significantly, leaving him with approximately 370,702 shares valued at $1.56 million. 股票以3.89美元关闭,减少了0.30美元,交易量很大。 The stock closed at $3.89, down $0.30, with heavy trading volume. Dominari是一家开发抗癌症疗法的生物技术公司,市场上限为6 228万美元,并获得一致的“稳住”评级。 Dominari, a biotech firm developing anticancer therapies, has a market cap of $62.28 million and a consensus “Hold” rating. 销售在证交会档案中披露。 The sales were disclosed in an SEC filing.